Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients – A lifetime analysis

OBJECTIVE: Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depressive Disorder (MDD) after patients have failed to benefit from trials of multiple antidepressant medications. No analysis to date has examined the cost-effectiveness of rTMS used earlier...

Descripción completa

Detalles Bibliográficos
Autores principales: Voigt, Jeffrey, Carpenter, Linda, Leuchter, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658110/
https://www.ncbi.nlm.nih.gov/pubmed/29073256
http://dx.doi.org/10.1371/journal.pone.0186950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658110/
https://www.ncbi.nlm.nih.gov/pubmed/29073256
http://dx.doi.org/10.1371/journal.pone.0186950

Ejemplares similares